The Nasdaq-listed Strategy, formerly MicroStrategy, is on the rise ahead of reporting earnings—just as Bitcoin's price jumps.

Of the 30 companies on the list, 17 saw their stock prices decrease, 11 saw their share prices increase, and two had their stock prices remain flat.

This project focuses on integrating Siemens' advanced control and data systems into Aduro's Next Generation Pilot Plant, ...

NeoGenomics has paid off in full the remaining $201.25 million in principal amount outstanding of its 1.25% Convertible ...

The listing, which will tentatively go live on May 16, could increase Galaxy Digital’s access to capital from U.S. investors.

ATHENS, Greece, April 30, 2025 (GLOBE NEWSWIRE) -- Capital Clean Energy Carriers Corp. (NASDAQ: CCEC) today announced that its board of directors has declared a cash dividend per share of $0.15 for ...

NeoGenomics shares dropped 34% on April 29 after missing its Q1 revenue estimates. Check out why I view the stock price ...

Q1 2025 Earnings Call Transcript April 29, 2025 NeoGenomics, Inc. misses on earnings expectations. Reported EPS is $-0.20352 ...

NeoGenomics Inc (NEO) reports an 8% revenue increase and strategic advancements, despite challenges in the non-clinical sector.

Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) fell 34.8% in the afternoon session after the ...

The stock market has been mostly flat this morning, but things have gotten slightly more positive as Amazon (NASDAQ: AMZN) ...

NeoGenomics (NASDAQ:NEO) stock gains as the company missed expectations with its Q1 2025 revenue, but raised full-year guidance, signalling growth ahead. Read more here.